WEBULL

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

Simply Wall St · 05/09 20:08

Integrated Research Limited (ASX:IRI) shareholders would be excited to see that the share price has had a great month, posting a 29% gain and recovering from prior weakness. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 26% over that time.

Even after such a large jump in price, Integrated Research may still be sending buy signals at present with its price-to-sales (or "P/S") ratio of 1.3x, considering almost half of all companies in the Software industry in Australia have P/S ratios greater than 3x and even P/S higher than 7x aren't out of the ordinary. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.

We've discovered 3 warning signs about Integrated Research. View them for free.

Check out our latest analysis for Integrated Research

ps-multiple-vs-industry
ASX:IRI Price to Sales Ratio vs Industry May 9th 2025

How Integrated Research Has Been Performing

Integrated Research hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. The P/S ratio is probably low because investors think this poor revenue performance isn't going to get any better. So while you could say the stock is cheap, investors will be looking for improvement before they see it as good value.

Keen to find out how analysts think Integrated Research's future stacks up against the industry? In that case, our free report is a great place to start.

Is There Any Revenue Growth Forecasted For Integrated Research?

The only time you'd be truly comfortable seeing a P/S as low as Integrated Research's is when the company's growth is on track to lag the industry.

Retrospectively, the last year delivered a frustrating 1.3% decrease to the company's top line. This means it has also seen a slide in revenue over the longer-term as revenue is down 7.0% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.

Turning to the outlook, the next year should generate growth of 5.1% as estimated by the one analyst watching the company. That's shaping up to be materially lower than the 31% growth forecast for the broader industry.

In light of this, it's understandable that Integrated Research's P/S sits below the majority of other companies. Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.

What We Can Learn From Integrated Research's P/S?

Integrated Research's stock price has surged recently, but its but its P/S still remains modest. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that Integrated Research maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises. The company will need a change of fortune to justify the P/S rising higher in the future.

Before you settle on your opinion, we've discovered 3 warning signs for Integrated Research (1 is potentially serious!) that you should be aware of.

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.